Our firm is the leading practice in Israel in the life sciences fields (medical devices, pharma, and digital health). Our attorneys advise founders, companies, incubators, investors, funds, research institutions, and multinational medical centers and the world’s largest insurers.
Our clients in the medical device field develop solutions for intensive care complications, disease detection, treatment of heart and heart-related diseases, solutions for measurement problems related to medications, nutrition, and more.
We represent dozens of companies that develop drugs. Our clients develop orphan drugs of all types, for cancer, skin diseases, and cosmetic purposes.
Our firm has also been recognized as one of the leading firms in Israel in the field of digital health. We advise on the connection between software, artificial intelligence (AI), deep learning (DL), education and medicine, big data, telehealth (online medicine), general health services, or wearable technology.
- We represent our clients in complex transactions including: licensing and development;
- Clinical trial agreements;
- Agreements with clinical research organizations (CROs);
- Agreements with clinical and regulatory consultants;
- Supply and manufacturing agreements;
- Commercialization agreements, including distribution, resale, and sublicense agreements.
These transactions require an understanding of market issues and standards relating to liability, privacy, cybersecurity, insurance, and quality of care. Our firm is considered at the forefront of these standards.
Our understanding of the limits of liability and inherent risks in these areas allows us to provide comprehensive advice on a wide range of corporate and financial issues and challenges facing companies in this field, including:
Financing and investment by venture capital funds, institutional bodies, government offices and authorities, as well as private investors;
GDPR (General Data Protection Regulation of the European Union) and privacy and database protection under the Israeli Privacy Protection Law;
Employment and consulting agreements, equity incentive plans, compensation policies, and benefits for directors, other officers, employees, and consultants;
General legal and commercial advice to companies and corporations; exit strategies, including the sale of assets, exclusive license agreements, initial public offerings, follow-on offerings and stock exchange listings, and mergers and acquisitions.
